MXCT
MaxCyte, Inc. · Healthcare
President and CEO Douglas Doerfler sold $221K of MaxCyte, Inc.
Sold$220,859
$5.04Price
43,851Shares
−12%Stake
What MXCT did after the filing
- The stock from Thu, Jun 15 close, $5.03
- −11.1%
- S&P 500, same days
- +3.8%
Measured over 30 trading days, to the Jul 31 close.
Traded Tue, Jun 13. Filed Thu, Jun 15, 12:30 PM ET, during the session. Returns use the Jun 15 close and the Jul 31 close. Not investment advice.